Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC, Greengard P.

J Neurosci. 2000 Jun 15;20(12):4480-8.

2.

The role of DARPP-32 in the actions of drugs of abuse.

Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P.

Neuropharmacology. 2004;47 Suppl 1:14-23. Review.

PMID:
15464122
3.

Mechanisms by which dopamine receptors may influence synaptic plasticity.

Wolf ME, Mangiavacchi S, Sun X.

Ann N Y Acad Sci. 2003 Nov;1003:241-9. Review.

PMID:
14684450
4.

DARPP-32: an integrator of neurotransmission.

Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P.

Annu Rev Pharmacol Toxicol. 2004;44:269-96. Review.

PMID:
14744247
5.

The phosphorylation state of DARPP-32, a third messenger for dopamine, is regulated by in vivo pharmacological treatments.

Di Luca M, Cimino M, Cattabeni F.

Neurochem Int. 1992 Mar;20 Suppl:165S-170S. Review.

PMID:
1365418
6.

DARPP-32 mediates the actions of multiple drugs of abuse.

Svenningsson P, Nairn AC, Greengard P.

AAPS J. 2005 Oct 5;7(2):E353-60. Review.

7.

Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.

Greengard P, Allen PB, Nairn AC.

Neuron. 1999 Jul;23(3):435-47. Review. No abstract available.

8.

The DARPP-32/protein phosphatase-1 cascade: a model for signal integration.

Greengard P, Nairn AC, Girault JA, Ouimet CC, Snyder GL, Fisone G, Allen PB, Fienberg A, Nishi A.

Brain Res Brain Res Rev. 1998 May;26(2-3):274-84. Review. No abstract available.

PMID:
9651542
9.

[Physiological function of cyclin-dependent kinase 5 in neuron].

Wei FY, Tomizawa K.

Seikagaku. 2005 May;77(5):436-9. Review. Japanese. No abstract available.

PMID:
15952336

Supplemental Content

Support Center